Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Editor Choice
Coave Therapeutics reveals lead gene therapy program, CoTx-101 | Ophthalmology Times
(Image Credit: AdobeStock) Coave Therapeutics has announced its lead gene therapy program,…
Brain Stimulation Boosts Vision Recovery After Stroke
A new study from researchers at EPFL introduces a promising non-invasive brain…
Trifocal IOL for Presbyopia Correction
Presbyopia continues to be one of the most significant visual limitations following…
Foundation Fighting Blindness releases 4-year RUSH2A data to public | Ophthalmology Times
(Image Credit: AdobeStock/Ar_TH) Foundation Fighting Blindness has granted public access to de-identified…
Opus Genetics doses first patient in phase 1/2 clinical trial, BIRD-1, evaluating OPGx-BEST1 | Ophthalmology Times
(Image Credit: AdobeStock/Treecha) Opus Genetics has dosed the first patient in its…
Eradicating Demodex Blepharitis and Improving MGD with Lotilaner | Ophthalmology Times
The program begins with a discussion on the everyday challenges eye care…
Enova Advanced EDoF IOL with Light Tailoring Tech
The Enova Advanced® Extended Depth of Focus (EDoF) IOL, developed by VSY Biotechnology…
AAO 2025: The rise of presbyopia research | Ophthalmology Times
AnnMarie Hipsley, PDT, PhD, founder of ACE Vision Group spoke to the…
STAAR Surgical announces amendments to Alcon merger agreement, further delays deal | Ophthalmology Times
(Image Credit: AdobeStock/Andrey Popov) The timeline for the proposed Alcon acquisition of…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Osheru Receives Funding for Ziplyft Device for Blepharoplasty
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Subscribe Now
Enter your email address below and subscribe to our newsletter






















